0.10Open0.18Pre Close14 Volume3.07K Open Interest78.00Strike Price209.00Turnover95.05%IV1.69%PremiumDec 13, 2024Expiry Date0.00Intrinsic Value100Multiplier1DDays to Expiry0.40Extrinsic Value100Contract SizeAmericanOptions Type-0.3857Delta0.1088Gamma80.95Leverage Ratio-0.8558Theta-0.0007Rho-31.22Eff Leverage0.0141Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet